title: Lifestyle of metabolically healthy obese individuals.
abstract: OBJECTIVE
  The aim of this study is to find factors associated with metabolic syndrome in obese individuals and thus offer guidance to stay metabolically healthy if obese.
  
  
  METHODS
  A cardiovascular screening programme performed in Finland during the years 2005-2007, identified 901 obese white individuals. Of them, 269 (30%) were metabolically healthy according to the Harmonization criteria of metabolic syndrome.
  
  
  RESULTS
  In multivariate logistic regression analysis, male sex [odds ratio (OR) 1.44 (95% CI 1.01-2.07)], living alone [OR 1.77 (95% CI 1.18-2.65)], physical inactivity [OR 3.73 (95% CI 1.24-11.24)], and use of betablockers [OR 2.63 (95% CI 1.75-3.95)] were associated with metabolic syndrome.
  
  
  CONCLUSIONS
  Even mild or occasional physical exercise is beneficial to health in obese individuals. Betablockers may not be the antihypertensive agents of choice when treating obese hypertensive individuals.
authors.affiliation: Satakunta Hospital District, 28100 Pori, Finland; Central Satakunta Health Federation of Municipalities, 29200 Harjavalta, Finland; Institute of Clinical Medicine, Family Medicine, University of Turku, 20520 Turku, Finland. Electronic address: paivi.e.korhonen@fimnet.fi.
authors.forename: Päivi E
authors.initials: PE
authors.lastname: Korhonen
authors.affiliation: Satakunta Hospital District, 28100 Pori, Finland. Electronic address: pirkko.korsoff@satshp.fi.
authors.forename: Pirkko
authors.initials: P
authors.lastname: Korsoff
authors.affiliation: University of Turku, 20520 Turku, Finland. Electronic address: tero.vahlberg@utu.fi.
authors.forename: Tero
authors.initials: T
authors.lastname: Vahlberg
authors.affiliation: Satakunta Hospital District, 28100 Pori, Finland; Institute of Clinical Medicine, Internal Medicine, University of Turku, 20520 Turku, Finland. Electronic address: risto.kaaja@utu.fi.
authors.forename: Risto
authors.initials: R
authors.lastname: Kaaja
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D016009:Chi-Square Distribution; D003430:Cross-Sectional Studies; D015444:Exercise; D005260:Female; D005387:Finland / Q000453:epidemiology; D006304:Health Status; D006801:Humans; D008019:Life Style; D016015:Logistic Models; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D008875:Middle Aged; D015999:Multivariate Analysis; D000067329:Obesity, Metabolically Benign / Q000175:diagnosis / Q000453:epidemiology*; D016017:Odds Ratio; D015995:Prevalence; D065840:Protective Factors; D012307:Risk Factors; D040242:Risk Reduction Behavior; D057185:Sedentary Behavior; D012737:Sex Factors; D012847:Single Person
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents
keywords: Metabolic syndrome; Obesity; Physical activity